Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

NEW BRUNSWICK, N.J., June 16, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 14th, to review second-quarter results.  Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Sandi Peterson, Group Worldwide Chairman; Dominic Caruso, Vice President, Finance and Chief Financial Officer and Louise Mehrotra, Vice President, Investor Relations, will host the call.

Investors and other interested parties may access the conference call in the following ways:

  • At Johnson & Johnson's website: www.investor.jnj.com. This earnings webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads.  A webcast and podcast replay will be available approximately two hours after the conference call concludes.
  • By telephone: For both "listen-only" participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-527-6580.  For participants outside the U.S., the dial-in number is 631-513-4629. The conference ID number for all callers is 68352415.  A replay of the conference call will be available beginning at approximately 1:00 p.m. on July 14, 2015, and ending at approximately 12:00 a.m. on July 22, 2015. The replay dial-in number for U.S. participants is 855-859-2056. For participants outside the U.S., the replay dial-in number is 404-537-3406. The replay conference ID number for all callers is 68352415.
  • Presentation materials will be available on www.investor.jnj.com.

About Johnson & Johnson

Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 127,000 employees at more than 265 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-to-host-investor-conference-call-on-second-quarter-results-300100181.html

SOURCE Johnson & Johnson

Suggested Articles

Sixteen years after it was approved, the FDA has ordered that heartburn drug Zantac and its generics be removed from the market.

In a non-randomized study in China, Avigan cleared virus after a median 4 days, significantly shorter than the 11 days observed for AbbVie's Kaletra.

Pfizer's 1.1-million-square-foot sterile injectables plant in Visakhapatnam has been criticized by the FDA for poor quality testing.